NAV

Uracil mustard

Identification

Generic Name
Uracil mustard
DrugBank Accession Number
DB00791
Background

Nitrogen mustard derivative of uracil. It is a alkylating antineoplastic agent that is used in lymphatic malignancies, and causes mainly gastrointestinal and bone marrow damage.

Type
Small Molecule
Groups
Approved
Structure
3D
Similar Structures
Weight
Average: 252.098
Monoisotopic: 251.022832025
Chemical Formula
C8H11Cl2N3O2
Synonyms
  • 5-(di-2-chloroethyl)aminouracil
  • 5-[bis(2-chloroethyl)amino]-2,4(1H,3H)-pyrimidinedione
  • 5-[bis(2-chloroethyl)amino]uracil
  • 5-[di(β-chloroethyl)amino]uracil
  • 5-aminouracil mustard
  • 5-N,N-bis(2-chloroethyl)aminouracil
  • Aminouracil mustard
  • Uracil mustard
  • Uracil nitrogen mustard
  • Uramustina
  • Uramustine
  • Uramustinum
External IDs
  • CB-4835
  • NSC-34462
  • SK-19849
  • U 8344
  • U-8344
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Used for its antineoplastic properties.

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Uracil Mustard selectively inhibits the synthesis of deoxyribonucleic acid (DNA). The guanine and cytosine content correlates with the degree of Uracil Mustard-induced cross-linking. At high concentrations of the drug, cellular RNA and protein synthesis are also suppressed.

Mechanism of action

After activation, it binds preferentially to the guanine and cytosine moieties of DNA, leading to cross-linking of DNA, thus inhibiting DNA synthesis and function.

TargetActionsOrganism
UDNA
intercalation
Humans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

5%

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
Integrate drug-drug
interactions in your software
AmbroxolThe risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Ambroxol.
ArticaineThe risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Articaine.
BenzocaineThe risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Benzocaine.
Benzyl alcoholThe risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Benzyl alcohol.
BupivacaineThe risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Bupivacaine.
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
International/Other Brands
Uracil Mustard (Upjohn)

Categories

ATC Codes
L01AD08 — Uramustine
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as nitrogen mustard compounds. These are compounds having two beta-haloalkyl groups bound to a nitrogen atom.
Kingdom
Organic compounds
Super Class
Organic nitrogen compounds
Class
Organonitrogen compounds
Sub Class
Nitrogen mustard compounds
Direct Parent
Nitrogen mustard compounds
Alternative Parents
Dialkylarylamines / Pyrimidones / Aminopyrimidines and derivatives / Hydropyrimidines / Vinylogous amides / Heteroaromatic compounds / Ureas / Lactams / Azacyclic compounds / Organopnictogen compounds
show 5 more
Substituents
Alkyl chloride / Alkyl halide / Amine / Aminopyrimidine / Aromatic heteromonocyclic compound / Azacycle / Dialkylarylamine / Heteroaromatic compound / Hydrocarbon derivative / Hydropyrimidine
show 15 more
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
nitrogen mustard, aminouracil (CHEBI:9884)
Affected organisms
  • Humans and other mammals

Chemical Identifiers

UNII
W7KQ46GJ8U
CAS number
66-75-1
InChI Key
IDPUKCWIGUEADI-UHFFFAOYSA-N
InChI
InChI=1S/C8H11Cl2N3O2/c9-1-3-13(4-2-10)6-5-11-8(15)12-7(6)14/h5H,1-4H2,(H2,11,12,14,15)
IUPAC Name
5-[bis(2-chloroethyl)amino]-1,2,3,4-tetrahydropyrimidine-2,4-dione
SMILES
ClCCN(CCCl)C1=CNC(=O)NC1=O

References

General References
Not Available
Human Metabolome Database
HMDB0014929
KEGG Drug
D06265
KEGG Compound
C11686
PubChem Compound
6194
PubChem Substance
46506168
ChemSpider
5959
RxNav
10996
ChEBI
9884
ChEMBL
CHEMBL1488
ZINC
ZINC000000002235
Therapeutic Targets Database
DAP000990
PharmGKB
PA451830
Wikipedia
Uramustine

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
  • Shire development inc
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)206 dec °CPhysProp
water solubility1070 mg/LNot Available
logP1.2Not Available
Predicted Properties
PropertyValueSource
Water Solubility1.32 mg/mLALOGPS
logP0.79ALOGPS
logP0.41Chemaxon
logS-2.3ALOGPS
pKa (Strongest Acidic)8.76Chemaxon
pKa (Strongest Basic)-4.4Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area61.44 Å2Chemaxon
Rotatable Bond Count5Chemaxon
Refractivity58.35 m3·mol-1Chemaxon
Polarizability23.08 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.8672
Blood Brain Barrier+0.7711
Caco-2 permeable-0.6657
P-glycoprotein substrateSubstrate0.5716
P-glycoprotein inhibitor INon-inhibitor0.7111
P-glycoprotein inhibitor IINon-inhibitor0.9146
Renal organic cation transporterNon-inhibitor0.63
CYP450 2C9 substrateNon-substrate0.7045
CYP450 2D6 substrateNon-substrate0.7938
CYP450 3A4 substrateNon-substrate0.5662
CYP450 1A2 substrateNon-inhibitor0.8493
CYP450 2C9 inhibitorNon-inhibitor0.6858
CYP450 2D6 inhibitorNon-inhibitor0.894
CYP450 2C19 inhibitorInhibitor0.5511
CYP450 3A4 inhibitorNon-inhibitor0.7064
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.6569
Ames testAMES toxic0.718
CarcinogenicityNon-carcinogens0.9019
BiodegradationNot ready biodegradable0.9962
Rat acute toxicity3.4851 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Strong inhibitor0.6391
hERG inhibition (predictor II)Non-inhibitor0.5087
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0frf-1930000000-b082a72f43cd6ef8d865
Mass Spectrum (Electron Ionization)MSsplash10-0w29-9730000000-047cc283312feb25a4ed
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0udi-0090000000-ae3b20b0fd4b6a60eec1
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-001i-9000000000-af512a45faff31b5f64f
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-114l-3950000000-8b8745cddefa63df198e
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-001i-9000000000-252f199f3a2f39e48e78
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-001i-9200000000-4bde38aa78b6717dc30e
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-03dl-6910000000-7c791a338ec327d16c29
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-147.9510538
predicted
DarkChem Lite v0.1.0
[M-H]-143.31447
predicted
DeepCCS 1.0 (2019)
[M+H]+148.4148538
predicted
DarkChem Lite v0.1.0
[M+H]+147.14577
predicted
DeepCCS 1.0 (2019)
[M+Na]+147.9510538
predicted
DarkChem Lite v0.1.0
[M+Na]+156.44334
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. DNA
Kind
Nucleotide
Organism
Humans
Pharmacological action
Unknown
Actions
Intercalation
DNA is the molecule of heredity, as it is responsible for the genetic propagation of most inherited traits. It is a polynucleic acid that carries genetic information on cell growth, division, and function. DNA consists of two long strands of nucleotides twisted into a double helix and held together by hydrogen bonds. The sequence of nucleotides determines hereditary characteristics. Each strand serves as the template for subsequent DNA replication and as a template for mRNA production, leading to protein synthesis via ribosomes.
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Hartley JA, Forrow SM, Souhami RL: Effect of ionic strength and cationic DNA affinity binders on the DNA sequence selective alkylation of guanine N7-positions by nitrogen mustards. Biochemistry. 1990 Mar 27;29(12):2985-91. [Article]

Drug created at June 13, 2005 13:24 / Updated at December 02, 2023 06:55